---
title: "Yasons Chemex Care Ltd (YCCL) — Share Price, Financials & Analysis"
symbol: "YCCL"
company: "Yasons Chemex Care Ltd"
canonical: "https://tapetide.com/stocks/YCCL"
isin: "INE08S201019"
nse_symbol: "YCCL"
sector: "Commodities"
industry: "Chemicals & Petrochemicals"
market_cap_cr: 16.6
generated_at: "2026-09-13T18:26:23.683Z"
---

# Yasons Chemex Care Ltd (YCCL)

Canonical page: https://tapetide.com/stocks/YCCL

## Company

- **NSE Symbol:** YCCL
- **ISIN:** INE08S201019
- **Sector:** Commodities
- **Industry:** Chemicals & Petrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2023-08-03
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** yasonschemexcare.com

## About

Incorporated in 2017, Yasons Chemex Care Ltd is in the business of Trading of chemicals and manufacturing of dyes and inter mediates and FMCG Products[1]

## Latest Price

- **Price:** ₹8.5
- **Change:** -0.1 (-1.16%)
- **Open:** ₹8.6
- **Day High:** ₹8.6
- **Day Low:** ₹8.3
- **Previous Close:** ₹8.6
- **Volume:** 12000
- **As Of:** 2026-09-11T09:40:23+00:00

## Key Fundamentals

Observed at 2026-09-11T04:39:50.624506Z.

- **Market Cap:** ₹16.6 Cr
- **Classification:** SME
- **P/E (reported):** 17.5
- **EPS (reported):** ₹0.65
- **Book Value:** ₹21.53
- **Price to Book:** 0.4
- **Dividend Yield:** 0%
- **ROE:** 3.98%
- **ROCE:** 8.98%
- **Debt to Equity:** 0.32
- **Revenue (yearly):** ₹96.82 Cr
- **Net Income:** ₹0.93 Cr
- **EBITDA:** ₹-0.6 Cr
- **52-Week High:** ₹13.95
- **52-Week Low:** ₹8
- **RSI (14):** 41.29

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-08-26
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Falling
- **Percentile:** 35.8 (of 4468 scored stocks)
- **Confidence:** 86%
- **Data coverage:** 71%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 49.03 | 9% |
| growth | 70.58 | 9% |
| momentum | 37.5 | 12% |
| ownership | 50 | 24% |
| quality | 31.45 | 22% |
| valuation | 51.95 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.39 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 3.44% over last 3 years.
- Earnings include an other income of Rs.3.77 Cr.
- Company has high debtors of 158 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 84.9% | -807.41% | 1.61% |
| ebitda margin growth | -111.76% | -111.83% | — |
| net income growth | -41.88% | -35% | — |
| revenue growth | 22.09% | 38% | — |
| roce | 13.53% | -58.27% | — |
| roe | 24.76% | 7.9% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12 | 24.77 | 37.53 | 31.71 | 29.38 | 47.15 | 49.27 | 47.55 |
| Expenses | 11.23 | 25.06 | 34.55 | 32.08 | 26.81 | 48.47 | 47.54 | 49.88 |
| Operating Profit | 0.77 | -0.29 | 2.98 | -0.37 | 2.57 | -1.32 | 1.73 | -2.33 |
| OPM % | 6.42 | -1.17 | 7.94 | -1.17 | 8.75 | -2.8 | 3.51 | -4.9 |
| Other Income | 2.72 | 1.52 | 1.07 | -0.11 | 0.61 | 2.18 | 0.13 | 3.64 |
| Interest | 0.18 | 0.23 | 0.49 | 0.84 | 0.68 | 0.75 | 0.61 | 0.66 |
| Depreciation | 0.05 | 0.05 | 0.21 | 0.21 | 0.19 | 0.19 | 0.04 | 0.33 |
| Profit before tax | 3.26 | 0.95 | 3.35 | -1.53 | 2.31 | -0.08 | 1.21 | 0.32 |
| Tax % | 17.79 | 22.11 | 15.52 | 1.96 | 18.61 | 225 | 16.53 | 125 |
| Net Profit | 2.69 | 0.74 | 2.82 | -1.57 | 1.88 | -0.25 | 1.02 | -0.08 |
| EPS in Rs | 4.56 | 0.52 | 1.46 | -0.81 | 0.97 | -0.13 | 0.53 | -0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 36.77 | 36.77 | 69.24 | 76.53 | 96.82 |
| Expenses | 36.28 | 36.28 | 66.64 | 75.26 | 97.41 |
| Operating Profit | 0.49 | 0.49 | 2.6 | 1.27 | -0.59 |
| OPM % | 1.33 | 1.33 | 3.76 | 1.66 | -0.61 |
| Other Income | 4.23 | 4.23 | 0.96 | 2.78 | 3.77 |
| Interest | 0.41 | 0.41 | 1.33 | 1.44 | 1.28 |
| Depreciation | 0.1 | 0.1 | 0.43 | 0.38 | 0.37 |
| Profit before tax | 4.21 | 4.21 | 1.8 | 2.23 | 1.53 |
| Tax % | 18.76 | 18.76 | 30.56 | 27.35 | 38.56 |
| Net Profit | 3.43 | 3.43 | 1.25 | 1.62 | 0.94 |
| EPS in Rs | 5.81 | 2.42 | 0.65 | 0.84 | 0.49 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | — | 14.16 | 19.3 | 19.3 | 19.3 |
| Reserves | — | 6.56 | 19.77 | 21.38 | 22.26 |
| Borrowings | — | 3.47 | 8.52 | 11.16 | 13.37 |
| Other Liabilities | — | 3.4 | 7 | 7.49 | 13 |
| Total Liabilities | — | 27.59 | 54.59 | 59.33 | 67.93 |
| Fixed Assets | — | 0.52 | 3.15 | 2.84 | 2.72 |
| CWIP | — | 0 | 0 | 0 | 0 |
| Investments | — | 6.59 | 0 | 0 | 0 |
| Other Assets | — | 20.48 | 51.44 | 56.49 | 65.21 |
| Total Assets | — | 27.59 | 54.59 | 59.33 | 67.93 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -0.27 | -16.22 | -2.45 | -0.74 |
| Cash from Investing Activity | — | 0.06 | 0 | -0.01 | -0.26 |
| Cash from Financing Activity | — | 0.24 | 17.6 | 1.22 | 0.93 |
| Net Cash Flow | — | 0.03 | 1.38 | -1.23 | -0.07 |
| Free Cash Flow | — | -0.27 | -16.24 | -2.51 | -0.98 |
| CFO/OP | — | 59 | -599 | -136 | -10 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | — | 113.06 | 151.29 | 143.75 | 157.96 |
| Inventory Days | — | 82.74 | 83.94 | 96.36 | 80.86 |
| Days Payable | — | 30.01 | 26.48 | 24.09 | 39.54 |
| Cash Conversion Cycle | — | 165.79 | 208.75 | 216.02 | 199.28 |
| Working Capital Days | — | 139.77 | 181.71 | 173.65 | 141.14 |
| ROCE % | — | — | 8.71 | 7.37 | 5.26 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% | 51.47% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 40.52% | 40.29% | 40.85% | 40.1% | 40.32% | 40.68% |
| Others | 8.01% | 8.25% | 7.69% | 8.43% | 8.21% | 7.86% |
| No. of Shareholders | 1387 | 1330 | 1272 | 1192 | 1223 | 1188 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 9.03 | Sell |
| EMA (10) | 8.97 | Sell |
| SMA (20) | 9.38 | Sell |
| EMA (20) | 9.24 | Sell |
| SMA (50) | 9.67 | Sell |
| EMA (50) | 9.65 | Sell |
| SMA (100) | 10.18 | Sell |
| EMA (100) | 10.2 | Sell |
| SMA (200) | 11.25 | Sell |
| EMA (200) | 11.44 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.44 | Neutral |
| MACD (12,26,9) | -0.31 | Sell |
| Stochastic (14,3,3) | 28.47 | Neutral |
| ADX (14) | 18.1 | Neutral |
| Williams %R (14) | -79.17 | Neutral |
| ATR (14) | 0.56 | High Volatility |
| ROC (12) | -12.37 | Sell |
| Stoch RSI (14) | 9.75 | Buy |
| UO (7,14,28) | 47.88 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 8 Sep - Newspaper publication filed for 9th AGM notice, annual report 2025-26, book closure and e-voting details. | [Copy of Newspaper Publication 8 Sep - Newspaper publication filed for 9th AGM notice, annual report 2025-26, book closure and e-voting details.](https://nsearchives.nseindia.com/corporate/YASONS_08092026134021_Newspaper_publication.pdf) |
| 8 May 2026 - Promoter disclosed 99,35,400 shares held as of March 31, 2026; no encumbrance during FY2026. | [Disclosure under SEBI Takeover Regulations 8 May 2026 - Promoter disclosed 99,35,400 shares held as of March 31, 2026; no encumbrance during FY2026.](https://nsearchives.nseindia.com/corporate/team_bbodade_16042026170939_YCCL1.pdf) |
| 7 Sep - AGM on 30 Sept 2026; e-voting 27-29 Sept; seeks approval for Rs.50 crore RPTs. | [Shareholders meeting 7 Sep - AGM on 30 Sept 2026; e-voting 27-29 Sept; seeks approval for Rs.50 crore RPTs.](https://nsearchives.nseindia.com/corporate/YASONS_07092026155545_AGM_2026_Notice.pdf) |
| 6 March 2026 - Appointed Bhaveshkumar Rajnikant Shah as Independent Director (6 Mar 2026–5 Mar 2031); committees reconstituted. | [Appointment 6 March 2026 - Appointed Bhaveshkumar Rajnikant Shah as Independent Director (6 Mar 2026–5 Mar 2031); committees reconstituted.](https://nsearchives.nseindia.com/corporate/YASONS_06032026171856_outcome.pdf) |
| 6 March 2026 - Appointed Bhaveshkumar R. Shah as Independent Director from 6 Mar 2026–5 Mar 2031; board committees reconstituted. | [Outcome of Board Meeting 6 March 2026 - Appointed Bhaveshkumar R. Shah as Independent Director from 6 Mar 2026–5 Mar 2031; board committees reconstituted.](https://nsearchives.nseindia.com/corporate/YASONS_06032026171356_outcome.pdf) |
| 30 April 2026 - Yasons Chemex Care confirms it is not a Large Corporate as of March 31, 2026. | [Updates 30 April 2026 - Yasons Chemex Care confirms it is not a Large Corporate as of March 31, 2026.](https://nsearchives.nseindia.com/corporate/YASONS_30042026183832_LC_March_2026_Yasons.pdf) |
| 29 May 2026 - No deviation in ₹2,056.8 lakh public issue proceeds as of 31 March 2026. | [Statement of deviation(s) or variation(s) under Reg. 32 29 May 2026 - No deviation in ₹2,056.8 lakh public issue proceeds as of 31 March 2026.](https://nsearchives.nseindia.com/corporate/YASONS_29052026181129_Reg_32_March_2026.pdf) |
| 29 May 2026 - Half-year ended 31 Mar 2026 statement shows no deviation in Rs2,056.8 lakh public issue proceeds. | [Utilisation of Funds 29 May 2026 - Half-year ended 31 Mar 2026 statement shows no deviation in Rs2,056.8 lakh public issue proceeds.](https://nsearchives.nseindia.com/corporate/YASONS_29052026181259_Reg_32_March_2026.pdf) |
| 29 May 2026 - Board approved audited standalone and consolidated FY26 results on 29 May 2026; auditors gave unmodified opinion. | [Outcome of Board Meeting 29 May 2026 - Board approved audited standalone and consolidated FY26 results on 29 May 2026; auditors gave unmodified opinion.](https://nsearchives.nseindia.com/corporate/YASONS_29052026174732_FinalOutcome.pdf) |
| 26 June 2026 - Board approved audited standalone and consolidated FY2026 results; standalone profit after tax Rs 93.78 lakh, unmodified opinion. | [Updates 26 June 2026 - Board approved audited standalone and consolidated FY2026 results; standalone profit after tax Rs 93.78 lakh, unmodified opinion.](https://nsearchives.nseindia.com/corporate/YASONS_26062026181921_Yasons_financials_march_2025.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_31685_YCCL_2025_2026_A_1690148_07092026155914.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28894_YCCL_2024_2025_A_1581734_08092025143549.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25958_YCCL_2023_2024_06092024135947.pdf) |
| from nse | [Annual Report 2023 from nse](https://archives.nseindia.com/annual_reports/SME_AR_23060_YCCL_2022_2023_29082023165415_08292023170001.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:23.683Z.